{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:01:00Z","timestamp":1791568860077,"version":"4.3.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T00:00:00Z","timestamp":1520812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12964-018-0222-5","type":"journal-article","created":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T08:49:03Z","timestamp":1520844543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells"],"prefix":"10.1186","volume":"16","author":[{"given":"Yuanyuan","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Berlind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala","family":"Mavila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,12]]},"reference":[{"key":"222_CR1","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers H, Nusse R. Wnt\/beta-catenin signaling and disease. Cell. 2012;149:1192\u2013205.","journal-title":"Cell"},{"key":"222_CR2","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1053\/j.gastro.2015.02.056","volume":"148","author":"SP Monga","year":"2015","unstructured":"Monga SP. Beta-catenin signaling and roles in liver homeostasis, injury, and tumorigenesis. Gastroenterology. 2015;148:1294\u2013310.","journal-title":"Gastroenterology"},{"key":"222_CR3","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/sj.onc.1208433","volume":"24","author":"H Ma","year":"2005","unstructured":"Ma H, Nguyen C, Lee KS, et al. Differential roles for the coactivators CBP and p300 on TCF\/beta-catenin-mediated survivin gene expression. Oncogene. 2005;24:3619\u201331.","journal-title":"Oncogene"},{"key":"222_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/hep.22704","volume":"49","author":"L Mishra","year":"2009","unstructured":"Mishra L, Banker T, Murray J, et al. Liver stem cells and hepatocellular carcinoma. Hepatology. 2009;49:318\u201329.","journal-title":"Hepatology"},{"key":"222_CR5","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1038\/sj.onc.1209558","volume":"25","author":"T Roskams","year":"2006","unstructured":"Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene. 2006;25:3818\u201322.","journal-title":"Oncogene"},{"key":"222_CR6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nature09781","volume":"469","author":"JE Visvader","year":"2011","unstructured":"Visvader JE. Cells of origin in cancer. Nature. 2011;469:314\u201322.","journal-title":"Nature"},{"key":"222_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105\u201311.","journal-title":"Nature"},{"key":"222_CR8","doi-asserted-by":"publisher","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","volume":"66","author":"MF Clarke","year":"2006","unstructured":"Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells--perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 2006;66:9339\u201344.","journal-title":"Cancer Res"},{"key":"222_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/path.2283","volume":"214","author":"D Mizrak","year":"2008","unstructured":"Mizrak D, Brittan M, Alison M. CD133: molecule of the moment. J Pathol. 2008;214:3\u20139.","journal-title":"J Pathol"},{"key":"222_CR10","doi-asserted-by":"publisher","first-page":"12425","DOI":"10.1073\/pnas.94.23.12425","volume":"94","author":"A Weigmann","year":"1997","unstructured":"Weigmann A, Corbeil D, Hellwig A, et al. Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci U S A. 1997;94:12425\u201330.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"222_CR11","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/hep.22141","volume":"47","author":"CB Rountree","year":"2008","unstructured":"Rountree CB, Senadheera S, Mato JM, et al. Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice. Hepatology. 2008;47:1288\u201397.","journal-title":"Hepatology"},{"key":"222_CR12","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/hep.22743","volume":"49","author":"W Ding","year":"2009","unstructured":"Ding W, Mouzaki M, You H, et al. CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis. Hepatology. 2009;49:1277\u201386.","journal-title":"Hepatology"},{"key":"222_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.canlet.2009.08.010","volume":"289","author":"Q Zhang","year":"2010","unstructured":"Zhang Q, Shi S, Yen Y, et al. A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett. 2010;289:151\u201360.","journal-title":"Cancer Lett"},{"key":"222_CR14","doi-asserted-by":"publisher","first-page":"16281","DOI":"10.1073\/pnas.0905653106","volume":"106","author":"G Bertolini","year":"2009","unstructured":"Bertolini G, Roz L, Perego P, et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A. 2009;106:16281\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"222_CR15","doi-asserted-by":"publisher","first-page":"E60","DOI":"10.3390\/cancers8070060","volume":"8","author":"EMF de Sousa","year":"2016","unstructured":"de Sousa EMF, Vermeulen L. Wnt signaling in cancer stem cell biology. Cancers (Basel). 2016;8:E60.","journal-title":"Cancers (Basel)"},{"key":"222_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ceb.2007.02.007","volume":"19","author":"R Fodde","year":"2007","unstructured":"Fodde R, Brabletz T. Wnt\/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol. 2007;19:150\u20138.","journal-title":"Curr Opin Cell Biol"},{"key":"222_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ceb.2013.01.004","volume":"25","author":"JD Holland","year":"2013","unstructured":"Holland JD, Klaus A, Garratt AN, et al. Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol. 2013;25:254\u201364.","journal-title":"Curr Opin Cell Biol"},{"key":"222_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/CCO.0b013e32831d1faf","volume":"21","author":"I Malanchi","year":"2009","unstructured":"Malanchi I, Huelsken J. Cancer stem cells: never Wnt away from the niche. Curr Opin Oncol. 2009;21:41\u20136.","journal-title":"Curr Opin Oncol"},{"key":"222_CR19","doi-asserted-by":"publisher","first-page":"12682","DOI":"10.1073\/pnas.0404875101","volume":"101","author":"KH Emami","year":"2004","unstructured":"Emami KH, Nguyen C, Ma H, et al. A small molecule inhibitor of beta-catenin\/CREB-binding protein transcription [corrected]. Proc Natl Acad Sci U S A. 2004;101:12682\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"222_CR20","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/cas.12471","volume":"105","author":"HJ Lenz","year":"2014","unstructured":"Lenz HJ, Kahn M. Safely targeting cancer stem cells via selective catenin coactivator antagonism. Cancer Sci. 2014;105:1087\u201392.","journal-title":"Cancer Sci"},{"key":"222_CR21","doi-asserted-by":"publisher","first-page":"e50401","DOI":"10.1371\/journal.pone.0050401","volume":"7","author":"N Mavila","year":"2012","unstructured":"Mavila N, James D, Utley S, et al. Fibroblast growth factor receptor-mediated activation of AKT-beta-catenin-CBP pathway regulates survival and proliferation of murine hepatoblasts and hepatic tumor initiating stem cells. PLoS One. 2012;7:e50401.","journal-title":"PLoS One"},{"key":"222_CR22","doi-asserted-by":"publisher","first-page":"24148","DOI":"10.1074\/jbc.M116.744045","volume":"291","author":"K Ramani","year":"2016","unstructured":"Ramani K, Mavila N, Ko KS, et al. Prohibitin 1 regulates the H19-Igf2 Axis and proliferation in hepatocytes. J Biol Chem. 2016;291:24148\u201359.","journal-title":"J Biol Chem"},{"key":"222_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2174\/1573406054864098","volume":"1","author":"M Eguchi","year":"2005","unstructured":"Eguchi M, Nguyen C, Lee SC, et al. ICG-001, a novel small molecule regulator of TCF\/beta-catenin transcription. Med Chem. 2005;1:467\u201372.","journal-title":"Med Chem"},{"key":"222_CR24","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/hep.27203","volume":"60","author":"N Mavila","year":"2014","unstructured":"Mavila N, James D, Shivakumar P, et al. Expansion of prominin-1-expressing cells in association with fibrosis of biliary atresia. Hepatology. 2014;60:941\u201353.","journal-title":"Hepatology"},{"key":"222_CR25","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/hep.28964","volume":"65","author":"W Fan","year":"2017","unstructured":"Fan W, Yang H, Liu T, et al. Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells. Hepatology. 2017;65:1249\u201366.","journal-title":"Hepatology"},{"key":"222_CR26","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1073\/pnas.0811212106","volume":"106","author":"M Rahdar","year":"2009","unstructured":"Rahdar M, Inoue T, Meyer T, et al. A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN. Proc Natl Acad Sci U S A. 2009;106:480\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"222_CR27","doi-asserted-by":"publisher","first-page":"7491","DOI":"10.1073\/pnas.0932835100","volume":"100","author":"S Das","year":"2003","unstructured":"Das S, Dixon JE, Cho W. Membrane-binding and activation mechanism of PTEN. Proc Natl Acad Sci U S A. 2003;100:7491\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"222_CR28","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1073\/pnas.96.5.2110","volume":"96","author":"S Ramaswamy","year":"1999","unstructured":"Ramaswamy S, Nakamura N, Vazquez F, et al. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase\/Akt pathway. Proc Natl Acad Sci U S A. 1999;96(5):2110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"222_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1530\/JOE-13-0172","volume":"220","author":"A Tsuchiya","year":"2014","unstructured":"Tsuchiya A, Kanno T, Nishizaki T. PI3 kinase directly phosphorylates Akt1\/2 at Ser473\/474 in the insulin signal transduction pathway. J Endocrinol. 2014;220:49\u201359.","journal-title":"J Endocrinol"},{"key":"222_CR30","doi-asserted-by":"publisher","first-page":"11221","DOI":"10.1074\/jbc.M611871200","volume":"282","author":"D Fang","year":"2007","unstructured":"Fang D, Hawke D, Zheng Y, et al. Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J Biol Chem. 2007;282:11221\u20139.","journal-title":"J Biol Chem"},{"key":"222_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2013.02.036","volume":"335","author":"P Seshacharyulu","year":"2013","unstructured":"Seshacharyulu P, Pandey P, Datta K, et al. Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer. Cancer Lett. 2013;335:9\u201318.","journal-title":"Cancer Lett"},{"key":"222_CR32","doi-asserted-by":"publisher","first-page":"11691","DOI":"10.1007\/s13277-016-5145-4","volume":"37","author":"G Grech","year":"2016","unstructured":"Grech G, Baldacchino S, Saliba C, et al. Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options. Tumour Biol. 2016;37:11691\u2013700.","journal-title":"Tumour Biol"},{"key":"222_CR33","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1042\/bj2560283","volume":"256","author":"C Bialojan","year":"1988","unstructured":"Bialojan C, Takai A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem J. 1988;256:283\u201390.","journal-title":"Biochem J"},{"key":"222_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.molcel.2010.12.030","volume":"41","author":"V Stanevich","year":"2011","unstructured":"Stanevich V, Jiang L, Satyshur KA, et al. The structural basis for tight control of PP2A methylation and function by LCMT-1. Mol Cell. 2011;41:331\u201342.","journal-title":"Mol Cell"},{"key":"222_CR35","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1038\/oncsis.2015.17","volume":"4","author":"YJ Su","year":"2015","unstructured":"Su YJ, Chang YW, Lin WH, et al. An aberrant nuclear localization of E-cadherin is a potent inhibitor of Wnt\/beta-catenin-elicited promotion of the cancer stem cell phenotype. Oncogene. 2015;4:e157.","journal-title":"Oncogene"},{"key":"222_CR36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","volume":"1","author":"PC Hermann","year":"2007","unstructured":"Hermann PC, Huber SL, Herrler T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 2007;1:313\u201323.","journal-title":"Cell Stem Cell"},{"key":"222_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature05372","volume":"445","author":"CA O'Brien","year":"2007","unstructured":"O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445:106\u201310.","journal-title":"Nature"},{"key":"222_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature05384","volume":"445","author":"L Ricci-Vitiani","year":"2007","unstructured":"Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007;445:111\u20135.","journal-title":"Nature"},{"key":"222_CR39","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"SK Singh","year":"2004","unstructured":"Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396\u2013401.","journal-title":"Nature"},{"key":"222_CR40","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444:756\u201360.","journal-title":"Nature"},{"key":"222_CR41","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1038\/sj.onc.1210811","volume":"27","author":"S Ma","year":"2008","unstructured":"Ma S, Lee TK, Zheng BJ, et al. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt\/PKB survival pathway. Oncogene. 2008;27:1749\u201358.","journal-title":"Oncogene"},{"key":"222_CR42","doi-asserted-by":"publisher","first-page":"e59154","DOI":"10.1371\/journal.pone.0059154","volume":"8","author":"L Wen","year":"2013","unstructured":"Wen L, Chen XZ, Yang K, et al. Prognostic value of cancer stem cell marker CD133 expression in gastric cancer: a systematic review. PLoS One. 2013;8:e59154.","journal-title":"PLoS One"},{"key":"222_CR43","doi-asserted-by":"publisher","first-page":"42019","DOI":"10.18632\/oncotarget.5714","volume":"6","author":"L Yiming","year":"2015","unstructured":"Yiming L, Yunshan G, Bo M, et al. CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis. Oncotarget. 2015;6:42019\u201327.","journal-title":"Oncotarget"},{"key":"222_CR44","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1634\/stemcells.2008-0332","volume":"27","author":"CB Rountree","year":"2009","unstructured":"Rountree CB, Ding W, He L, et al. Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice. Stem Cells. 2009;27:290\u20139.","journal-title":"Stem Cells"},{"key":"222_CR45","doi-asserted-by":"publisher","first-page":"1248012","DOI":"10.1126\/science.1248012","volume":"346","author":"H Clevers","year":"2014","unstructured":"Clevers H, Loh KM, Nusse R. Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control. Science. 2014;346:1248012.","journal-title":"Science"},{"key":"222_CR46","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.1073\/pnas.1217002110","volume":"110","author":"Y Wei","year":"2013","unstructured":"Wei Y, Jiang Y, Zou F, et al. Activation of PI3K\/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells. Proc Natl Acad Sci U S A. 2013;110:6829\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"222_CR47","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1158\/1078-0432.CCR-11-3066","volume":"18","author":"K Kemper","year":"2012","unstructured":"Kemper K, Versloot M, Cameron K, et al. Mutations in the Ras-Raf Axis underlie the prognostic value of CD133 in colorectal cancer. Clin Cancer Res. 2012;18:3132\u201341.","journal-title":"Clin Cancer Res"},{"key":"222_CR48","first-page":"2235","volume":"29","author":"K Hibi","year":"2009","unstructured":"Hibi K, Sakata M, Kitamura YH, et al. Demethylation of the CD133 gene is frequently detected in advanced colorectal cancer. Anticancer Res. 2009;29:2235\u20137.","journal-title":"Anticancer Res"},{"key":"222_CR49","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1002\/hep.23544","volume":"51","author":"H You","year":"2010","unstructured":"You H, Ding W, Rountree CB. Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta. Hepatology. 2010;51:1635\u201344.","journal-title":"Hepatology"},{"key":"222_CR50","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/bj3530417","volume":"353","author":"V Janssens","year":"2001","unstructured":"Janssens V, Goris J. Protein phosphatase 2A: a highly regulated family of serine\/threonine phosphatases implicated in cell growth and signalling. Biochem J. 2001;353:417\u201339.","journal-title":"Biochem J"},{"key":"222_CR51","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1172\/JCI63672","volume":"123","author":"R Patel","year":"2013","unstructured":"Patel R, Gao M, Ahmad I, et al. Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression. J Clin Invest. 2013;123:1157\u201375.","journal-title":"J Clin Invest"},{"issue":"6","key":"222_CR52","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1172\/JCI89548","volume":"127","author":"J Sangodkar","year":"2017","unstructured":"Sangodkar J, Perl A, Tohme R, et al. Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth. J Clin Invest. 2017;127(6):2081\u201390.","journal-title":"J Clin Invest"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-018-0222-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12964-018-0222-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-018-0222-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T20:18:23Z","timestamp":1552335503000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-018-0222-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,12]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["222"],"URL":"https:\/\/doi.org\/10.1186\/s12964-018-0222-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733070908.793580840","asserted-by":"object"}]},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,12]]},"assertion":[{"value":"2 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"9"}}